These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14744348)

  • 1. Is there a role for pentosan polysulfate in the prevention of calcium oxalate stones?
    Jones M; Monga M
    J Endourol; 2003 Dec; 17(10):855-8. PubMed ID: 14744348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentosan polysulfate as an inhibitor of calcium oxalate crystal growth.
    Martin X; Werness PG; Bergert JH; Smith LH
    J Urol; 1984 Oct; 132(4):786-8. PubMed ID: 6206244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of crystallization on urolithiasis in vitro].
    Miyazawa K; Suzuki K; Tsugawa R
    Hinyokika Kiyo; 1991 Oct; 37(10):1091-6. PubMed ID: 1721765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of sodium pentosan polysulphate and certain inhibitors on calcium oxalate crystal growth.
    Senthil D; Subha K; Saravanan N; Varalakshmi P
    Mol Cell Biochem; 1996 Mar; 156(1):31-5. PubMed ID: 8709973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium pentosan polysulphate--a novel inhibitor of urinary risk factors and enzymes in experimental urolithiatic rats.
    Senthil D; Malini MM; Varalakshmi P
    Ren Fail; 1998 Jul; 20(4):573-80. PubMed ID: 9713875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of glycosaminoglycans induced in newly formed calcium oxalate crystals using an undiluted urine system.
    Suzuki K; Tsugawa R
    Scanning Microsc; 1995; 9(4):1089-95; discussion 1095-6. PubMed ID: 8819890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preventive effect of sodium pentosan polysulfate against renal stone formation in hyperoxaluric rats.
    Nakatani T; Ishii K; Yoneda Y; Kamikawa S; Kanazawa T; Sugimoto T; Osswald H
    Urol Res; 2002 Oct; 30(5):329-35. PubMed ID: 12389123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Inhibitory effect of sodium pentosan polysulfate on the formation, growth and aggregation of calcium oxalate in vitro].
    Suzuki K; Miyazawa K; Tsugawa R
    Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):526-31. PubMed ID: 2473238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies of sodium pentosan polysulphate (SPP) therapy on the urinary stone disease. Experimental studies on the calcium oxalate crystallization and the effects in healthy subjects].
    Fukatani T
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):246-53. PubMed ID: 1710303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of inhibitory effect of chondroitin polysulfate on stone formation of calcium oxalate].
    Fujisawa M; Arima S; Yachiku S
    Nihon Hinyokika Gakkai Zasshi; 1992 Oct; 83(10):1647-54. PubMed ID: 1434267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentosan polysulfate sodium for treatment of interstitial cystitis/bladder pain syndrome: insights from a randomized, double-blind, placebo controlled study.
    Nickel JC; Herschorn S; Whitmore KE; Forrest JB; Hu P; Friedman AJ; Baseman AS
    J Urol; 2015 Mar; 193(3):857-62. PubMed ID: 25245489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of factors affecting calcium oxalate crystalline aggregation.
    Grases F; Costa-Bauzá A
    Br J Urol; 1990 Sep; 66(3):240-4. PubMed ID: 1698500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Alkalinizing treatment as a preventative of recurrent calcium oxalate lithiasis].
    Cifuentes Delatte L
    Arch Esp Urol; 1991 Oct; 44(8):903-10. PubMed ID: 1796852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicochemical considerations in the development and prevention of calcium oxalate urolithiasis.
    Kok DJ; Papapoulos SE
    Bone Miner; 1993 Jan; 20(1):1-15. PubMed ID: 8453319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of citrate on the different phases of calcium oxalate crystallization.
    Tiselius HG; Berg C; Fornander AM; Nilsson MA
    Scanning Microsc; 1993 Mar; 7(1):381-9; discussion 389-90. PubMed ID: 8316807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium pentosan polysulphate as a polyanionic inhibitor of calcium oxalate crystallization in vitro and in vivo.
    Norman RW; Scurr DS; Robertson WG; Peacock M
    Clin Sci (Lond); 1985 Mar; 68(3):369-71. PubMed ID: 2578913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The quantitative study of inhibitory effect of pentosan polysulfate and chlorophyllin on the experimental calcium oxalate stone].
    Miyazawa K; Suzuki K; Tsugawa R
    Nihon Hinyokika Gakkai Zasshi; 1989 Jun; 80(6):861-9. PubMed ID: 2477580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of calcium oxalate crystallisation by pentosan polysulphate in control subjects and stone formers.
    Norman RW; Scurr DS; Robertson WG; Peacock M
    Br J Urol; 1984 Dec; 56(6):594-8. PubMed ID: 6085478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serum lipids and lipoproteins in calcium oxalate stone forming rats treated with sodium pentosan polysulphate.
    Subha K; Sivamurugesan A; Varalakshmi P
    Biochem Int; 1992 Sep; 27(6):1011-8. PubMed ID: 1280138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.